Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity

NCT04612270 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT04612270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04612270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity
Lead sponsor
Medical University Innsbruck
Phase
Not applicable
Overall status
Completed
Start date
November 4, 2020
Completion date
June 1, 2021
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxygen deficiency